News summary: Dow extends streak of advances

Published



ANOTHER GAIN: The Dow Jones industrial average eked out a small gain and advanced for an eighth straight day. That’s the longest streak of gains for the index since February 2011.

DRUGS TEST: Merck pulled the Dow higher, advancing 3.2 percent to $45.04 after the drugmaker said a data safety monitoring board recommended that a study of its cholesterol drug Vytorin should continue.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.